Growth hormone secretory status is a determinant of the Thyrotropin response to Thyrotropin-releasing hormone in Euthyroid patients with Hypothalamic-Pituitary disease

45Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

To assess the influence of endogenous GH secretion on the TSH and T3 responses to TRH administration in patients with hypothalamic-pituitary disease, we analyzed tests in a selected group of 26 euthyroid patients with hypothalamicpituitary disease and in 15 normal controls. Basal TSH levels and the TSH response to TRH were significantly greater in GHdeficient patients (group 1) than in patients with normal anterior pituitary function and unimpaired GH reserve (group II). However, the T3 response to TRH was significantly less in group 1 than in group II patients. In acromegaly (group III), the TSH response to TRH was blunted, while basal and stimulated T3 levels were no different compared to control levels. These findings suggest that endogenous GH depresses the TSH response to TRH while enhancing the thyroid secretion of T3 in responseto the evoked TSH released. © 1981 by The Endocrine Society.

Cite

CITATION STYLE

APA

Cobb, W. E., Reichlin, S., & Jackson, I. M. D. (1981). Growth hormone secretory status is a determinant of the Thyrotropin response to Thyrotropin-releasing hormone in Euthyroid patients with Hypothalamic-Pituitary disease. Journal of Clinical Endocrinology and Metabolism, 52(2), 324–329. https://doi.org/10.1210/jcem-52-2-324

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free